—

Galenica Sante AG (GALE.SW) — the peer cohort

As of 2026-10-08 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Galenica Sante AG ranks 9 of 9 in its cohort on the Closelooknet composite (45/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GALE.SW Galenica Sante AG 45 37 30 64 info 16.9%
BION.SW BB Biotech AG 73 57 96 81 info 16.1%
SOON.SW Sonova H Ag 56 90 73 52 neutral 2.4%
YPSN.SW Ypsomed Holding AG 55 68 62 30 info 15%
MOVE.SW Medacta Group SA 48 10 58 33 warn 36.6%
HALO Halozyme Therapeutics Inc 74 94 94 51 ok 6%
DXCM DexCom Inc 66 83 80 37 watch 9%
ANN.AU Ansell Ltd 64 94 47 53 ok 1.7%
ONC BeiGene, Ltd. 64 77 64 32 info 9.1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-08

Quick answers

Who are Galenica Sante AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: BB Biotech AG (BION.SW), Sonova H Ag (SOON.SW), Ypsomed Holding AG (YPSN.SW), Medacta Group SA (MOVE.SW), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), Ansell Ltd (ANN.AU), BeiGene, Ltd. (ONC).

How does GALE.SW score against its peers?

Galenica Sante AG's composite reads 45/100, ranking 9 of 9 in its cohort as of 2026-10-08; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Distribution, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.